INZY
Inozyme Pharma Inc
Price:  
0.98 
USD
Volume:  
376,139.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INZY WACC - Weighted Average Cost of Capital

The WACC of Inozyme Pharma Inc (INZY) is 8.6%.

The Cost of Equity of Inozyme Pharma Inc (INZY) is 12.40%.
The Cost of Debt of Inozyme Pharma Inc (INZY) is 5.00%.

Range Selected
Cost of equity 9.90% - 14.90% 12.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.2% - 10.0% 8.6%
WACC

INZY WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.31 1.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.90% 14.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.78 0.78
Cost of debt 5.00% 5.00%
After-tax WACC 7.2% 10.0%
Selected WACC 8.6%